Results from the MONITOR HF trial, published in The Lancet, showedAbbott's CardioMEMS implantable hemodynamic monitor can improve heart failure patients’ quality of life.
Abbott's CardioMEMS Monitor Improves Quality Of Life In Study
Medtech Insight’s Cardiovascular Catch-Up highlights recent news on cardiovascular tech innovations that you may have missed. Here is an update from the MONITOR HF study of Abbott's CardioMEMS implantable hemodynamic monitor.
